Orelabrutinib Combined With Rituximab and Chemotherapy for Relapsed/Refractory B-Cell Lymphoma Patients With Central Nervous System Involvement

Condition:   CNS Lymphoma Interventions:   Drug: Orelabrutinib;   Drug: Rituximab;   Drug: Chemotherapy Sponsor:   Ruijin Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials